• Title/Summary/Keyword: Pricing Policy

Search Result 207, Processing Time 0.023 seconds

A Study on Evaluation of Online Trading System in MRO Supply Business

  • JEONG, Dongbin
    • The Journal of Economics, Marketing and Management
    • /
    • v.10 no.2
    • /
    • pp.1-13
    • /
    • 2022
  • Purpose: The findings are expected to be used as basic data for policy establishment for systematic support and upbringing of small and medium-sized suppliers through the current status and characteristics of the industrial structure of the MRO consumable materials industry as a whole and the market trend. Research design, data, and methodology: This survey is conducted in 2019 mainly for companies that operate consumable materials delivery business, and the survey size is about 25,000 in advance (selected) and about 2,000 in the main survey. Using cluster analysis and multidimensional scaling, we derive the visualization of the homogeneous grouping of cases and the relationship structure between them. Results: Based on the attributes of reason for not having an online trading system, it is classified into three and four clusters for industry and company size, respectively, and the feature and pattern of each individual can be are relatively evaluated and visualized. Conclusions: Small and medium-sized consumable material suppliers specialize in products rather than fierce pricing strategies or external expansion strategies and it is more effective to establish a plan to promote the growth of both large and small enterprises through cooperation with large corporations.

Evaluation of Factors for Effective Distribution of Covid-19 Vaccines

  • RAJU, Totakura Bangar;CHAKRABARTI, Deepankar;DAS, Neenu;MATHUR, Ravi Prakash
    • Journal of Distribution Science
    • /
    • v.20 no.7
    • /
    • pp.57-64
    • /
    • 2022
  • Purpose: The government of India has initiated the Covid-19 Vaccination drive from early January 2021. Vaccination is identified to be best option to protect the people across the globe. However, owing to fast wide spread of the Covid-19, the Vaccine Distribution is a major challenge owing various issues like temperature control, infrastructure, hesitancy, geographical diversity, and other critical factors. Various research is carried out globally to understand and study the Vaccine Distribution issues based on the respective country issues and factors. Research Design, Data, and Methodology: This research paper attempts to explore prominent factors that could be taken up on priority for better and effective vaccination program. The study tries to rank various factors and sub-factors affecting vaccine distribution in India. AHP methodology based on feedback from 22 experts from the Vaccine industry has been deployed to get the desired results. Result: The results show that factors vaccine approval process, geographical prioritization, power supply, infrastructure maintenance costs for vaccine storage, and vaccine pricing are the prominent factors of effective vaccination in the country. Conclusion: The role and need for district-level health officers towards vaccine storage has been brought forward. A long-term effective vaccination policy is needed for optimum vaccine distribution.

Research on The Development Strategy of Chinese Cross-Border E-Commerce SMEs under the Background of COVID-19

  • Shulei BI
    • Journal of Distribution Science
    • /
    • v.21 no.10
    • /
    • pp.1-9
    • /
    • 2023
  • Purpose: This study analyses the current development of cross-border e-commerce in China, outlines the challenges faced by Chinese cross-border e-commerce SMEs, and finally summarises the development strategies of Chinese cross-border e-commerce SMEs in the post-covid-19 era, which will provide opinion references for the development of Chinese cross-border e-commerce SMEs. Research design, data and methodology: The methodology used in this study is to analyse the current situation of cross-border e-commerce development in China in the context of covid-19 through literature; and to summarise the challenges encountered by Chinese cross-border e-commerce SMEs through semi-structured interviews. Results: The article summarises the current status of China's cross-border e-commerce development in the context of covid-19 in terms of cross-border e-commerce trade volume, cross-border e-commerce enterprise and user scale, cross-border e-commerce logistics, cross-border e-commerce global co-operation, government policy, and cross-border e-commerce product distribution, outlining challenges encountered by China's cross-border e-commerce SMEs in terms of logistic pricing, operating capital chain, product service support, and trade protection The paper Finally, it is pointed out that Chinese cross-border e-commerce SMEs must adopt new strategies to adapt to the new development in the context of covid-19. Conclusions: Specific development strategies are provided for Chinese cross-border e-commerce enterprises and reference suggestions are provided for the post-covid-19 era.

Software Bundling for Competitive Advantage: Vendor Strategies and Public Policy Implications

  • Kim, Tae-Ha;Shin, Hyung-Deok;Dutta, Amitava
    • Asia pacific journal of information systems
    • /
    • v.20 no.2
    • /
    • pp.39-62
    • /
    • 2010
  • As an engineered product, a software package has multiple dimensions that must be designed judiciously to enhance its competitive viability. Functionality, reliability and price are three such common dimensions. However, many software products are sold as bundles of individual components and the competitive impact of bundling has received less attention in the research literature. In this paper, we examine the implications of software vendors using bundling as an element of competitive strategy. A game theoretic model of the actions of an incumbent and a new entrant is developed and the impact on vendor and consumer welfare is analyzed. Numerical experiments with the model show that (i) increasing bundle size is an effective strategy for the incumbent to increase its payoff at the cost of the entrant's payoff and consumer surplus, especially when the entrant's quality is low (ii) in the presence of bundling, the entrant can still increase its own payoff and consumer surplus at the cost of the incumbent's payoff, by increasing product quality up to the level that best segments market demand with the incumbent and (iii) an increase in bundle size by the incumbent, or an increase in quality by the entrant, can both result in an increase of total surplus. Similar results are observed in a related case where the entrant offers free software bundles. Our results provide insights into how software vendors may strategically use bundling and quality as additional product dimensions in order to stay competitive in the market. These results also inform the competing vendors of the impact of bundling related public policy actions on their respective payoffs.

Cost-effectiveness Analysis of Pharmacologic Treatment in Hypercholesterolemia (고콜레스테롤혈증 치료 약물들에 대한 비용-효과 분석)

  • 정경래;문옥륜
    • Health Policy and Management
    • /
    • v.9 no.3
    • /
    • pp.70-94
    • /
    • 1999
  • This paper was performed for a cost-effectiveness analysis of pharmacologic treatment of hypercholesterolemia. Agents modeled were cholestyramine, gemfibrozil. bezafibrate, lovastatin, pravastatin, simvastatin. Pharmacologic effectiveness was estimated by regression from reported clinical trials. Pharmacologic effects were expressed as the percent change of blood cholesterol level. Cost estimates included patients' travel expenses and time loss as well as resource consumption in the health care sector. Bezafibrate was the most efficient agent for reducing total cholesterol levels, having an cost over 1 year of ₩31.400 per percent reduction in total cholesterol. Simvastatin (10mg/d) was also efficient(₩33,100 per percent reduction). Chole styramine(8g/d) was least efficient at ₩90,200. For low-density lipoprotein cholesterol. simvastatin(10mg/d) was most efficient, at ₩23,200 per percent reduction, followed by lovastatin(20mg/d) at ₩28,000. Gemfibrozil was least efficient at ₩77,800 per percent reduction. For high-density lipoprotein cholesterol. bezafibrate(400mg/d) was most efficient at ₩39,300 per percent increase of high-density lipoprotein cholesterol. Cholestyramine was least efficient at ₩514,700. Analyses combining low-density lipoprotein cholesterol and high-density cholesterol effects suggest that bezafibrate(600mg/d) and simvastatin (10mg/d) were most efficient for reducing cardiovascular risk. The cost-effectiveness analysis results show that both simvastatin and bezafibrate could be efficient treatment. Simvastatin provide more effective treatment at higher cost, whereas bezafibrate is more cost-effective, as it may be less effective, at lower cost. Therefore, clinicians should choose reasonable treatment according to the patient's needs This pharmacoeconimc analysis will provide a guideline for efficient pharmacologic treatment and also be reference data for pricing new drugs.

  • PDF

A Study on the Willingness to Pay of Decision Factor for Mobile IPTV (모바일 IPTV 서비스에 대한 지불의사 결정 요인 연구)

  • Kim, Dong-Woo;Yoo, Jae-Young;Joung, Won-Ko
    • Journal of Broadcast Engineering
    • /
    • v.19 no.3
    • /
    • pp.385-395
    • /
    • 2014
  • This study analyzes empirically main factors of willingness-to-pay for mobile IPTV emphasized as a key service in mobile environment. By structure equation analysis, the results shows that service diversity has influence on usefulness and service quality influences both usefulness and ease-to-use. Secondly, usability has positive impact on attitude and satisfaction. Thirdly, attitude and satisfaction influence willingness-to-pay. These result mean that quality assurance(ex, QoS) and improvement of usability are essential for revenue improvement revenue in mobile IPTV. And also this study can give empirical implications for service portfolio, pricing and bundling strategy as a leading study for mobile IPTV.

Scale and Structure of Pharmaceutical Expenditure for the year 2006 in Korea (우리나라 2006년 약제비의 규모 및 구성)

  • Jeong, Hyoung-Sun;Lee, Jun-Hyup
    • Health Policy and Management
    • /
    • v.18 no.3
    • /
    • pp.110-127
    • /
    • 2008
  • Expenditures on pharmaceuticals of different concepts were estimated and their functional, financing and providers' breakdowns were examined in line with the OECD's System of Health Accounts (SHA) manual. This study also shows the way such estimates are made. The results are then analyzed particularly from the international perspective. Data from both Household Survey by the National Statistical Office and the National Health and Nutritional Survey by the Ministry of Health and Welfare of Korea were used to estimate pharmaceutical expenditures that. are financed by out-of-pocket payments of the household, while national health insurance data etc. were used for estimation of pharmaceutical expenditures that are financed by public funding sources. The 'per capita expenditure on pharmaceutical/medical non-durables' in Korea stood at 380 US$ PPPs, less than the OECD average of 443 US$ PPPs in 2006, but its share of the per capita health expenditure of 25.9% noticeably outnumbered the OECD average of 17.1%, due partly to low per capita health expenditure as a denominator of the ratio. This indicates that Koreans tend to spend less on health care than an OECD average, while tending to spend more on pharmaceuticals than on other health care services, much like the pattern found in relatively low income countries. An international pharmaceuticals pricing mechanism is most likely responsible for such a tendency. In addition, it is to be noted that the percentage comes down to 21.0%, when expenditures on both medical non-durables and herbal medicine, which is locally quite popular among the elderly, have been excluded.

Analysis on the Determinants of Therapeutic Materials Expenditure in National Health Insurance (주요 치료재료 품목군의 건강보험청구액 결정요인분석)

  • Byeon, Jin Ok;Lee, Ju Hyang;Kim, Yu Ri;Lee, Hye Jae
    • Health Policy and Management
    • /
    • v.26 no.4
    • /
    • pp.333-342
    • /
    • 2016
  • Background: The use of therapeutic materials based on new health technology has increased in recent years in the field of medicine, raising concerns for medical practitioners regarding increased spending on the new therapeutic materials amid the rapid population ageing and increase of chronic diseases in Korea. While therapeutic materials have significant importance in the health care system, they have not been given appropriate attention in the academic world of Korea. The purpose of this study is to identify factors that affect the growth of expenditure on therapeutic materials and to derive implications for an effective management considering the diversity of therapeutic materials. Methods: Using the claims data of the National Health Insurance Services, specific utilization patterns of groups of therapeutic materials in the middle classification level of Health Insurance Review and Assessment Service from 2007 to 2014 were analyzed. Four categories (J5083: drug eluting coronary stent, D0302: nonmetallic anchor, K6014: gauze, K6023: gauze) that exhibit unique patterns with respect to price and volume were selected. Then, decomposition analysis was performed to identify the largest contributor to the spending growth by dividing the products into existing, new, and abandoned products for the period between 2010 and 2013. Results: The effect of new products had larger impact on spending growth than the effect of core items in drug eluting coronary stent (J5083) and nonmetallic anchor (D0302). In addition, existing products in general included items priced relatively lower when compared with another item manufactured by the same company. In the gauze category, however, existing products had the largest impact on expenditure and the effect of volume was greater than that in other categories. Conclusion: This study provides evidence that appropriate management measures classified by the characteristics of therapeutic materials are required for therapeutic materials pricing and reassessment in Korea.

Estimation of lapse rate of variable annuities by using Cox proportional hazard model (Cox 비례위험모형을 이용한 변액연금 해지율의 추정)

  • Kim, Yumi;Lee, Hangsuck
    • Journal of the Korean Data and Information Science Society
    • /
    • v.24 no.4
    • /
    • pp.723-736
    • /
    • 2013
  • The importance of lapse rate is highly increasing due to the introduction of Cash Flow Pricing system, non-refund-of-reserve insurance policy, and IFRS (International Financial Reporting System) to the Korean insurance market. Researches on lapse rate have mainly focused on simple data analysis and regression analysis, etc. However, lapse rate can be analyzed by survival analysis and can be well explained in terms of several covariates with Cox proportional hazard model. Guaranteed minimum benefits embedded in variable annuities require more elegant statistical analysis of lapse rate. Hence, this paper analyzes data of policyholders with variable annuities by using Cox proportional hazard model. The key variables of policy holder that influences the lapse rate are payment method, premium, lapse insured to term insured, reserve-GMXB ratio, and age.

Estimating the Economic Value of Radio Spectrum for Trunked Radio System (주파수 공용통신 용도 주파수의 경제적 가치 측정)

  • Byun, Hee Sub;Yeon, Kwon-Hum;Kim, Yongkyu
    • The Journal of Korean Institute of Electromagnetic Engineering and Science
    • /
    • v.30 no.5
    • /
    • pp.356-364
    • /
    • 2019
  • The Ministry of Science and ICT recently announced its policy direction that involves charging the economic value of radio spectrum for promoting its efficient usage. According to the policy, there will be much efforts to estimate the economic values of various usages of radio spectrum. In this study, the economic value of radio spectrum is estimated for trunked radio system(TRS) by employing the least cost alternative methodology. The proposed methodology estimates the value of radio spectrum according to the cost of an alternative that can be employed for providing the same service. The value of radio spectrum for TRS was determined on the basis of the cost associated with the provision of TRS through the LTE network, wherein the value of radio spectrum for TRS comprises the LTE network cost, capital expenditure for the LTE service, subsidy for the LTE handset, and compensation cost for migration. Results obtained from this study can aid in calculating the economic values of radio spectra for other services and applications.